Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-01

FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Verapamil Hydrochloride (Verapamil hydrochloride)

Snippet

SUPPL AP for VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE)